UPDATED SAFETY AND QUALITY OF LIFE (QOL) RESULTS OF PARAMOUNT STUDY: MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VS PLACEBO (PBO) PLUS BSC IMMEDIATELY FOLLOWING INDUCTION TREATMENT WITH PEM PLUS CISPLATIN (CP) FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NS-NSCLC)

被引：0
|
作者：
Pujol, J. [1 ]
Paz-Ares, L. [2 ]
Dediu, M. [3 ]
Thomas, M. [4 ]
Bidoli, P. [5 ]
Corral, J. [2 ]
Chouaki, N. [6 ]
Visseren-Grul, C. M. [7 ]
Zimmermann, A. [8 ]
Gridelli, C. [9 ]
机构：
[1] Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, France
[2] Hosp Univ Virgen del Rocio, Seville, Spain
[3] Fundeni Clin Hosp Alexandru Treistoreanu, Inst Oncol Bucharest, Bucharest, Romania
[4] Univ Heidelberg, Thoraxklin Heidelberg, Dept Thorac Oncol, D-6900 Heidelberg, Germany
[5] Azienda Osped S Gerardo UO Oncol Med, Monza, Italy
[6] Eli Lilly & Co, Dept Med, Paris, France
[7] Eli Lilly & Co, Oncol Europe, Ra Houten, Netherlands
[8] Eli Lilly & Co, Oncol, Indianapolis, IN 46285 USA
[9] UO Oncol Med SG Moscati Hosp, Avellino, Italy
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：418 / 419
页数：2
相关论文
共 50 条
  • [1] PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC)
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Thomas, M.
    Pujol, J.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Laack, E.
    Reck, M.
    Corral, J.
    Melemed, S. A.
    John, W. J.
    Chouaki, N.
    Zimmerman, A.
    Grul, C. M. Visseren
    Gridelli, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC)
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Thomas, M.
    Pujol, J.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Laack, E.
    Reck, M.
    Corral, J.
    Melem, S. A.
    Grul, C. M. Visseren
    Gridelli, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
  • [3] MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC AFTER PEM PLUS CISPLATIN FOR ADVANCED NONSQUAMOUS NSCLC
    Obasaju, C. K.
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Thomas, M.
    Pujol, J. L.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Laack, E.
    Reck, M.
    Corral, J.
    Melemed, S. A.
    John, W. J.
    Chouaki, N.
    Zimmermann, A.
    Visseren-Grul, C. M.
    Gridelli, C.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 8 - 8
  • [4] Overall survival (OS) of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC): final results of a phase Ill study (PARAMOUNT)
    Laack, E.
    Reck, M.
    Schumann, C.
    Eschbach, C.
    Kimmich, M.
    Brandts, C.
    Paz-Ares, L. G.
    De Marinis, F.
    Dediu, M.
    Pujol, J.-L.
    Bidoli, P.
    Molinier, O.
    Sahoo, T. P.
    Corral, J.
    Melemed, S. A.
    John, W. J.
    Chouaki, N.
    Zimmermann, A. H.
    Visseren-Grul, C. M.
    Leschinger, M., I
    Thomas, M.
    [J]. ONKOLOGIE, 2012, 35 : 36 - 37
  • [5] PARAMOUNT: Final overall survival (OS) results of the phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo (plb) plus BSC immediately following induction treatment with pem plus cisplatin (cis) for advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis
    De Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Pujol, Jean-Louis
    Bidoli, Paolo
    Molinier, Oliver
    Sahoo, Tarini Prasad
    Laack, Eckart
    Reck, Martin
    Jaime, Jesus Corral
    Melemed, Symantha
    John, William J.
    Chouaki, Nadia
    Zimmermann, Annamaria
    Visseren-Grul, Carla
    Gridelli, Cesare
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] SAFETY, RESOURCE USE, AND QUALITY OF LIFE (QOL) RESULTS FROM PARAMOUNT: A PHASE III STUDY OF MAINTENANCE PEMETREXED PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC IMMEDIATELY FOLLOWING INDUCTION TREATMENT WITH PEMETREXED-CISPLATIN FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Gridelli, Cesare
    De Marinis, Filippo
    Pujol, Jean-Louis
    Reck, Martin
    Ramlau, Rodryg
    Parente, Barbara
    Pieters, Thierry
    Middleton, Gary
    Winfree, Katherine
    Melemed, Symantha
    Zimmermann, Annamaria H.
    John, William
    Beyrer, Julie
    Chouaki, Nadia
    Visseren-Grul, Carla
    Paz Ares, Luis
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S323 - S324
  • [7] Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Brodowicz, T.
    Ciuleanu, T.
    Kim, J. H.
    Krzakowski, M.
    Laack, E.
    Wu, Y. L.
    Peterson, P.
    Krejcy, K.
    Zielinski, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [8] Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Brodowicz, T.
    Ciuleanu, T.
    Kim, J. H.
    Krzakowski, M.
    Laack, E.
    Wu, Y. L.
    Peterson, P.
    Krejcy, K.
    Zielinski, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] A RANDOMIZED PHASE 2 STUDY COMPARING MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS BSC ALONE FOLLOWING INDUCTION TREATMENT WITH PEM-CISPLATIN (CIS) IN ADVANCED NONSQUAMOUS (NONSQ) NON-SMALL CELL LUNG CANCER (NSCLC)
    Meshref, Mohamed
    Gaafar, Rabab M.
    Shehata, Samir
    Hashem, Tarek
    Gerges, Dani Abi
    Azim, Hamdy Abdel
    El-Husseiny, Gamal
    Al-Hussein, Hamed
    Liu, Zhixin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1263 - S1263
  • [10] Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Pujol, Jean-Louis
    Paz-Ares, Luis
    de Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Bidoli, Paolo
    Corral, Jesus
    San Antonio, Belen
    Chouaki, Nadia
    John, William
    Zimmermann, Annamaria
    Visseren-Grul, Carla
    Gridelli, Cesare
    [J]. CLINICAL LUNG CANCER, 2014, 15 (06) : 418 - 425
12345